These trials completed more than 12 months ago and should have reported results. Some have, some have not.

These trials are not yet due to report results: some are ongoing, some completed within the past 12 months.

These trials have problematic data on the registry. Details why »

Status Trial ID Title Completion date Category
Ongoing 2005-000371-18 The use of Thalidomide as a treatment for the cachexia of incurable upper gastrointestinal adenocarcinomas:a randomised, double-blinded, placebo controlled trial. not-yet-due
Ongoing 2005-000988-26 Cyclooxygenase inhibitor therapy in patients with oesophageal adenocarcinoma: A pilot study not-yet-due
Ongoing 2005-003285-42 A RCT to test the analgesic efficacy of topical morphine on minor and partial thickness burns in A&E not-yet-due
Not reported 2008-006080-36 Analgesic efficacy of ultrasound guided transversus abdominis plane block as part of a multimodal analgesic regime for post elective caesarean section pain – a comparative double-blinded placebo contr... 2015-05-01 due-trials
Not reported 2009-017537-21 Oral thiamine (Vitamin B1) supplementation in subjects with type 2 diabetes mellitus: a randomised, double-blind, placebo-controlled crossover trial assessing biophysical markers of endothelial functi... 2011-07-04 due-trials
Ongoing 2013-001097-24 Use of N-Acetylcysteine (NAC) and Simeticone as a pre-endoscopic drink to improve mucosal visualisation during gastroscopy: A randomised controlled trial not-yet-due
Ongoing 2014-002766-73 The effect of oral Vitamin D supplementation on endothelial function, vascular inflammation, oxidative stress and insulin sensitivity in patients with impaired fasting glucose: A randomised, double bl... not-yet-due
Ongoing 2014-005594-36 A Phase IV, Randomised, Double-Blind, Controlled, Parallel Group Trial to Evaluate the Effectiveness and Safety of Balneum Plus vs Emollient in the Treatment of Uraemic Pruritus in Haemodialysis Patie... not-yet-due
Ongoing 2017-001227-45 Comparison of ambulatory glucose profile prior to and during pancreatic enzyme replacement therapy in patients with diabetes and pancreatic exocrine insufficiency: a single-arm phase IV trial not-yet-due